CeriBell, Inc (CBLL) - Total Liabilities
Based on the latest financial reports, CeriBell, Inc (CBLL) has total liabilities worth $37.27 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
CeriBell, Inc - Total Liabilities Trend (2022–2025)
This chart illustrates how CeriBell, Inc's total liabilities have evolved over time, based on quarterly financial data. See CBLL net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
CeriBell, Inc Competitors by Total Liabilities
The table below lists competitors of CeriBell, Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Amsterdam Commodities NV
AS:ACOMO
|
Netherlands | €552.96 Million |
|
Washington Trust Bancorp Inc
NASDAQ:WASH
|
USA | $6.08 Billion |
|
Sinoma Energy Conservation Ltd
SHG:603126
|
China | CN¥3.08 Billion |
|
YIDU TECH INC. DL -00002
F:0EL
|
Germany | €719.75 Million |
|
Zhejiang Jindun Fans Co Ltd
SHE:300411
|
China | CN¥472.48 Million |
|
Oculis Holding AG Ordinary shares
NASDAQ:OCS
|
USA | $39.94 Million |
|
TSEC Corp
TW:6443
|
Taiwan | NT$3.30 Billion |
|
Akfen Yenilenebilir Enerji A.S.
IS:AKFYE
|
Turkey | TL16.84 Billion |
Liability Composition Analysis (2022–2025)
This chart breaks down CeriBell, Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see CBLL company net worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 10.30 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.26 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.21 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how CeriBell, Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for CeriBell, Inc (2022–2025)
The table below shows the annual total liabilities of CeriBell, Inc from 2022 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $40.47 Million | +18.16% |
| 2024-12-31 | $34.25 Million | -79.99% |
| 2023-12-31 | $171.17 Million | -0.97% |
| 2022-12-31 | $172.86 Million | -- |
About CeriBell, Inc
CeriBell, Inc. operates as a medical technology company in the United States. It develops the Ceribell System, a novel and point-of-care EEG platform specifically designed to address the unmet needs of patients in the acute care setting. The company also offers disposable, flexible headbands, and headcaps; and a pocket-sized, rechargeable battery-operated recorder used to capture and wirelessly t… Read more